Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 23 2018 - 8:00AM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook on Wednesday, September 5, at 11:40 a.m. ET at the 20th
Annual Rodman & Renshaw Global Investment Conference, sponsored
by H.C. Wainwright & Co., LLC. The conference is being
held on September 4-6, 2018, at the St. Regis New York Hotel
in New York City. A webcast of the company’s presentation will be
available live and archived through the Events & Presentations
page in the Investors section of the Vical website at
www.vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, including
antiviral and antifungal candidates. Additional information on
Vical is available at www.vical.com.
| |
|
|
| Contact: |
|
Andrew Hopkins |
| |
|
(858) 646-1127 |
| |
|
Website: www.vical.com |
Vical (NASDAQ:VICL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Nov 2023 to Nov 2024
